Cerner Co. (NASDAQ:CERN) Holdings Trimmed by United Capital Financial Advisers LLC

Share on StockTwits

United Capital Financial Advisers LLC lowered its position in shares of Cerner Co. (NASDAQ:CERN) by 2.3% in the 2nd quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 431,242 shares of the company’s stock after selling 10,375 shares during the quarter. United Capital Financial Advisers LLC owned 0.14% of Cerner worth $31,610,000 at the end of the most recent quarter.

A number of other hedge funds have also recently made changes to their positions in CERN. Dimensional Fund Advisors LP boosted its position in shares of Cerner by 25.8% in the 4th quarter. Dimensional Fund Advisors LP now owns 1,502,329 shares of the company’s stock valued at $78,781,000 after purchasing an additional 307,694 shares during the period. Geode Capital Management LLC boosted its position in shares of Cerner by 7.8% in the 4th quarter. Geode Capital Management LLC now owns 4,747,793 shares of the company’s stock valued at $248,593,000 after purchasing an additional 342,029 shares during the period. Robeco Institutional Asset Management B.V. boosted its position in shares of Cerner by 273.2% in the 1st quarter. Robeco Institutional Asset Management B.V. now owns 62,193 shares of the company’s stock valued at $3,559,000 after purchasing an additional 45,528 shares during the period. Victory Capital Management Inc. boosted its position in shares of Cerner by 6.3% in the 1st quarter. Victory Capital Management Inc. now owns 64,356 shares of the company’s stock valued at $3,682,000 after purchasing an additional 3,787 shares during the period. Finally, Mn Services Vermogensbeheer B.V. boosted its position in shares of Cerner by 5.8% in the 1st quarter. Mn Services Vermogensbeheer B.V. now owns 53,127 shares of the company’s stock valued at $3,039,000 after purchasing an additional 2,900 shares during the period. 83.22% of the stock is owned by institutional investors and hedge funds.

In other news, CFO Marc G. Naughton sold 24,110 shares of the firm’s stock in a transaction dated Friday, September 6th. The stock was sold at an average price of $67.58, for a total transaction of $1,629,353.80. Following the completion of the sale, the chief financial officer now directly owns 84,898 shares of the company’s stock, valued at approximately $5,737,406.84. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, VP Jeffrey A. Townsend sold 199,432 shares of the firm’s stock in a transaction dated Monday, September 9th. The stock was sold at an average price of $66.46, for a total value of $13,254,250.72. Following the sale, the vice president now directly owns 59,432 shares of the company’s stock, valued at $3,949,850.72. The disclosure for this sale can be found here. Insiders have sold a total of 288,377 shares of company stock valued at $19,427,390 over the last ninety days. Company insiders own 0.75% of the company’s stock.

Cerner stock traded up $0.11 during mid-day trading on Friday, hitting $68.12. The company’s stock had a trading volume of 68,196 shares, compared to its average volume of 1,850,965. The firm’s 50 day moving average is $70.10 and its 200 day moving average is $67.02. The company has a market cap of $21.65 billion, a PE ratio of 30.84, a price-to-earnings-growth ratio of 1.90 and a beta of 0.92. The company has a debt-to-equity ratio of 0.22, a current ratio of 2.52 and a quick ratio of 2.50. Cerner Co. has a 52-week low of $48.78 and a 52-week high of $76.47.

Cerner (NASDAQ:CERN) last announced its quarterly earnings data on Wednesday, July 24th. The company reported $0.60 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.58 by $0.02. The firm had revenue of $1.43 billion during the quarter, compared to the consensus estimate of $1.44 billion. Cerner had a return on equity of 15.14% and a net margin of 10.75%. The business’s revenue for the quarter was up 4.6% on a year-over-year basis. During the same period in the prior year, the business earned $0.62 EPS. As a group, analysts forecast that Cerner Co. will post 2.43 EPS for the current year.

The company also recently declared a quarterly dividend, which will be paid on Wednesday, October 9th. Stockholders of record on Wednesday, September 25th will be paid a dividend of $0.18 per share. This represents a $0.72 dividend on an annualized basis and a dividend yield of 1.06%. The ex-dividend date is Tuesday, September 24th. Cerner’s dividend payout ratio (DPR) is presently 32.58%.

A number of equities analysts recently weighed in on the company. Argus upgraded Cerner from a “hold” rating to a “buy” rating in a research report on Thursday, August 22nd. Wells Fargo & Co increased their price target on Cerner from $72.00 to $80.00 and gave the company an “outperform” rating in a research report on Thursday, July 25th. Morgan Stanley increased their price target on Cerner from $49.00 to $62.00 and gave the company an “underweight” rating in a research report on Friday, August 23rd. Jefferies Financial Group lowered Cerner from a “buy” rating to a “hold” rating and increased their price target for the company from $69.00 to $75.00 in a research report on Friday, August 23rd. Finally, Piper Jaffray Companies increased their price target on Cerner from $74.00 to $80.00 and gave the company an “overweight” rating in a research report on Thursday, July 25th. Two research analysts have rated the stock with a sell rating, five have assigned a hold rating and eleven have given a buy rating to the company. The stock has an average rating of “Buy” and an average target price of $74.73.

Cerner Company Profile

Cerner Corporation provides health care information technology solutions and tech-enabled services in the United States and internationally. The company offers Cerner Millennium architecture, a person-centric computing framework, which includes clinical, financial, and management information systems that allow providers to access an individual's electronic health record (EHR) at the point of care, and organizes and delivers information for physicians, nurses, laboratory technicians, pharmacists, front- and back-office professionals, and consumers.

Featured Story: Arbitrage

Institutional Ownership by Quarter for Cerner (NASDAQ:CERN)

Receive News & Ratings for Cerner Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cerner and related companies with MarketBeat.com's FREE daily email newsletter.